Among the plethora of novel agents against diabetes, GLP-1RAs are known to exert various biological effects in extra-pancreatic tissues beyond controlling hyperglycemia ( via central mechanisms ( Similarly, SGLT-2is, also referred to as gliflozins, represent another class of anti-hyperglycemic agents currently used in T2D treatment with favorable effects on body weight
The significantly better weight loss results with tirzepatide (22.5% versus 14.9% average) might be worth the slightly higher side effect risk for many people
doi: 10.1016/j.radonc.2021.04.015 30 CalderP
People with Overweight Conditions : For those who are overweight and have not achieved desired results with diet and exercise, GLP-1 medications can offer a viable alternative
Following instructions from a pamphlet, working through the uncertainty of equipment selection, wondering whether you are doing it right
[2], [3] Learn more Brain (satiety & reward): boosts satiety circuits and dampens food-reward drive less appetite & intake